Orchid is backed by world class experts in reproductive medicine and genetics committed to helping families understand and mitigate their reproductive risks. In our “Why They Joined” series, we highlight Orchid’s extraordinary scientific and medical advisors and what excites them most about Orchid.
What Barry Behr has to say about Orchid
“Over the years, I’ve seen firsthand the rapid evolution of genetic testing on embryos. The advent of advanced genetic technologies and the latest science allows us to optimize patients’ outcomes beyond just embryo viability. Predicting and preventing chronic common diseases is one of the 21st century’s greatest health challenges, and Orchid is paving the way for improving generational health for many future families.”
— Barry Behr, PhD, HCLD
Barry Behr’s Bio
Barry Behr, PhD, HCLD, is the Director of Stanford’s IVF Laboratory, Scientific Director for the RENEW Biobank, and Professor of Obstetrics and Gynecology at Stanford University. Dr. Behr has been widely recognized for his research, having published over 90 peer-reviewed publications, authored over 170 abstracts, and written 14 book chapters. He was the first non-M.D. President of the Pacific Coast Reproductive Society, and has been appointed as program chair of several professional meetings. As an entrepreneur, he has founded several fertility related businesses. Dr. Behr developed a culture medium for embryo culture to the blastocyst stage, which improved pregnancy rates, implantation rates and reduced the risks of multiple gestation in IVF. Dr. Behr earned his Ph.D. with emphasis in Reproductive Physiology in 1991, board certified as High Complexity Laboratory Director in 1994, and board certified as Embryology Laboratory Director in 2003.